Re-Emergence of Minimal Residual Disease Detected by Flow Cytometry Predicts an Adverse Outcome in Pediatric Acute Lymphoblastic Leukemia
PurposeWhile the role of minimal residual disease (MRD) assessment and the significance of achieving an MRD-negative status during treatment have been evaluated in previous studies, there is limited evidence on the significance of MRD re-emergence without morphological relapse in acute lymphoblastic...
Main Authors: | Yu Wang, Yu-Juan Xue, Yue-Ping Jia, Ying-Xi Zuo, Ai-Dong Lu, Le-Ping Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.596677/full |
Similar Items
-
Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemia
by: Maura Rosane Valério Ikoma, et al.
Published: (2015-12-01) -
Assessment of minimal residual disease in childhood acute lymphoblastic leukemia
by: Sonia K Parikh, et al.
Published: (2016-01-01) -
Individualized antigen expression in precursor T-cell acute lymphoblastic leukemia: A gate to minimal residual disease analysis by flow cytometry
by: Rasha Abd-El-Rahman El-Gamal, et al.
Published: (2022-01-01) -
Pediatric acute lymphoblastic leukemia treatment protocols improvement: emphasis on minimal residual disease
by: M. A. Shervashidze, et al.
Published: (2020-10-01) -
Flow cytometric minimal residual disease monitoring in children with acute lymphoblastic leukemia treated by regimens with reduced intensity
by: A. M. Popov, et al.
Published: (2015-12-01)